Plexaa
UK - LondonBiotechnology
Focus: Plexaa develops BLOOM, a wearable, sensor-controlled preconditioning device for breast surgery patients. The company operates in the specialized medical device/biotech space focused on surgical optimization.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Plexaa
AI assessmentNot HiringNo open roles listed right now. Follow Plexaa to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Pre-Commercial
Lead wearable device combining sensor technology with surgical preconditioning, but no commercial revenue or published trial data available.
Pipeline & Clinical Trials
BLOOM43
Nipple NecrosisHelp build intelligence for Plexaa
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.